| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |